small cell lung cancer

News

PharmaMar and Jazz sign $1bn US deal for lung cancer drug lu...

Spain's PharmaMar and Jazz Pharmaceuticals have signed a $1 billion license agreement for the lung cancer drug lurbinectedin in the US, which is being teed up for a launch in 2020.

News

AbbVie axes multi-billion cancer flop Rova-T after another t...

AbbVie has axed its troubled lung cancer drug Rova-T, after another trial failure from the drug that is turning out to be an expensive flop, costing almost $10 billion so far.

News

Opdivo and Keytruda approved in new lung cancer uses

The FDA has approved Merck's Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), after green-lighting Bristol-Myers Squibb’s (BMS)

PharmaMar and Jazz sign $1bn US deal for lung cancer drug lu...

AbbVie axes multi-billion cancer flop Rova-T after another t...

Opdivo and Keytruda approved in new lung cancer uses

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks